The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 2.97 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.76 — no flag raisedOK
- Earnings quality 97/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2026, as HAEMONETICS CORP reports it. History and quarterly detail are in the app.
- Hospital$588.3M
- Plasma$524.5M
- Blood Center$221.3M
Leadership changes
From HAEMONETICS CORP's own filings, the day they're filed.
- Charles J. Dockendorff · member · departureeff. 2026-04-27
Latest filings
- 8-K · Company announcement2026-08-18
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-28
- DEF 14A · Annual proxy (pay & governance)2026-06-09
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HAEMONETICS CORP, every answer cited to the official filings🔒
- The Intelligence Brief — added when HAEMONETICS CORP's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.